Fundraising Fox
Jim Healy
InvestorManaging Partner at Sofinnova Ventures
Menlo Park, California
Writes $100K – $5M checks · typically $1.5M
Find your path to Jim
Sign up to see every warm intro you have to Jim
- Paths you didn't know you had: your email and LinkedIn already hold routes to Jim. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Jim Healy has spent about twenty years investing at Sofinnova, backing thirty-two companies in the biotechnology and healthcare space, many of which have gone public or been acquired. He holds a B.A. in Molecular Biology and a B.A. in Scandinavian Studies from UC Berkeley, and earned his MD and PhD in Immunology from Stanford University through the NIH Medical Scientist Training Program. Before Sofinnova, he worked at Bayer (Miles) and Sanderling, and has lectured on entrepreneurship at Stanford.
Contact· self-published, not guessed
Invests in
BiotechHealthtechMedical Devices
Investments
Board seats
ArriVent (AVBP)BioAge (BIOA)CinCor (CINC)Karuna (KRTX)Rapport (RAPP)Seaport (SPTX)
Investor
Altamira TherapeuticsAmarin (AMRN)Anthera PharmaceuticalsApellis (APLS)ArriventAscendis (ASND)AtsenaAudentes (BOLD)Auris (EARS)BioAge LabsBolt (BOLT)CinCor PharmaDurata (DRTX)Edge (PDSB)Edge TherapeuticsHumanigenHyperion (HPTX)Hyperion TherapeuticsIterum (ITRM)Iterum TherapeuticsKaruna TherapeuticsMovetisNateraNatera (NTRA)NucanaNucana (NCNA)NuCana BioMedObsEvaObseva (OBSV)PregLemPrestwick PharmaceuticalsRapport TherapeuticsSeaport Therapeutics
Sources: the firm's website · curated public sources.
Colleagues at Sofinnova Ventures
Network2
Investors connected to Jim in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Jim Healy?
- Jim Healy has spent about twenty years investing at Sofinnova, backing thirty-two companies in the biotechnology and healthcare space, many of which have gone public or been acquired. He holds a B.A. in Molecular Biology and a B.A. in Scandinavian Studies from UC Berkeley, and earned his MD and PhD in Immunology from Stanford University through the NIH Medical Scientist Training Program. Before Sofinnova, he worked at Bayer (Miles) and Sanderling, and has lectured on entrepreneurship at Stanford.
- Where does Jim Healy work?
- Jim Healy is Managing Partner at Sofinnova Ventures.
- What does Jim Healy invest in?
- Jim Healy invests in Biotech, Healthtech, Medical Devices.
- What check size does Jim Healy write?
- Jim Healy typically writes checks of $100K – $5M.
- What boards does Jim Healy sit on?
- Jim Healy holds tracked board seats at ArriVent (AVBP), BioAge (BIOA), CinCor (CINC), Karuna (KRTX), Rapport (RAPP), Seaport (SPTX).
- What companies has Jim Healy invested in?
- Investments tracked here include Altamira Therapeutics, Amarin (AMRN), Anthera Pharmaceuticals, Apellis (APLS), Arrivent, Ascendis (ASND), Atsena, Audentes (BOLD), Auris (EARS), BioAge Labs, Bolt (BOLT), CinCor Pharma, and 21 more.
About this profile. Compiled from public sources — Sofinnova Ventures's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights